Arvinas
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Arvinas and other ETFs, options, and stocks.About ARVN
Arvinas, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its product candidates are ARV-110, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer, ARV-471, and ARV-766, a PROTAC protein degrader targeting the estrogen receptor protein for the treatment of patients with metastatic ER positive/HER2 negative breast cancer.
ARVN Key Statistics
Stock Snapshot
As of today, Arvinas(ARVN) shares are valued at $6.69. The company's market cap stands at 438.09M, with a P/E ratio of -36.68.
On 2026-11-10, Arvinas(ARVN) stock moved within a range of $6.49 to $6.81. With shares now at $6.69, the stock is trading +3.1% above its intraday low and -1.8% below the session's peak.
Trading volume for Arvinas(ARVN) stock has reached 227.56K, versus its average volume of 1.14M.
The stock's 52-week range extends from a low of $6.33 to a high of $14.51.
The stock's 52-week range extends from a low of $6.33 to a high of $14.51.
ARVN News
Arvinas, Inc. ( ) shareholders will have a reason to smile today, with the analysts making substantial upgrades to next year's forecasts. The revenue forecast f...
Analyst ratings
53%
of 15 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.